Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb 7;28(4):1589.
doi: 10.3390/molecules28041589.

Exploration of Succinimide Derivative as a Multi-Target, Anti-Diabetic Agent: In Vitro and In Vivo Approaches

Mater H Mahnashi  1 , Waqas Alam  2 , Mohammed A Huneif  3 , Alqahtani Abdulwahab  3 , Mohammed Jamaan Alzahrani  3 , Khaled S Alshaibari  3 , Umar Rashid  4 , Abdul Sadiq  5 , Muhammad Saeed Jan  6
Affiliations

Exploration of Succinimide Derivative as a Multi-Target, Anti-Diabetic Agent: In Vitro and In Vivo Approaches

Mater H Mahnashi et al. Molecules. .

Abstract

Diabetes mellitus (DM) is counted among one of the leading challenges in the recent era, and it is a life-threatening disorder. Compound 4-hydroxy 3-methoxy phenylacetone (compound 1) was previously isolated from Polygonum aviculare. This compound was reacted with N-benzylmaleimide to synthesize the targeted compound 3. The purpose of this research is to exhibit our developed compound 3's ability to concurrently inhibit many targets that are responsible for hyperglycemia. Compound 3 was capable of inhibiting α-amylase, α-glucosidase, and protein tyrosine phosphatase 1 B. Even so, outstanding in vitro inhibition was shown by the compound against dipeptidyl peptidase-4 (DPP-4) with an IC50 value of 0.07 µM. Additionally, by using DPPH in the antioxidant activity, it exhibited good antioxidant potential. Similarly, in the in vivo activity, the experimental mice proved to be safe by treatment with compound 3. After 21 days of examination, the compound 3 activity pattern was found to be effective in experimental mice. Compound 3 decreased the excess peak of total triglycerides, total cholesterol, AST, ALT, ALP, LDL, BUN, and creatinine in the STZ-induced diabetic mice. Likewise, the histopathology of the kidneys, liver, and pancreas of the treated animals was also evaluated. Overall, the succinimde moiety, such as compound 3, can affect several targets simultaneously, and, finally, we were successful in synthesizing a multi-targeted preclinical therapy.

Keywords: acute toxicity; antioxidant; diabetes; histopathology; succinimide.

PubMed Disclaimer

Conflict of interest statement

The authors affirm that there are no conflicts of interest and that our revised manuscript, now titled “Design, synthesis and Pharmacological Evaluation of succinimide derivative as multi target inhibitor of α-amylase, α-glucosidase, DPP4 and PTP-1 B for the treatment of type-II diabetes” has not been published or is not currently being considered for publishing in any journal, seminar, or conference.

Figures

Scheme 1
Scheme 1
Synthetic scheme for the reaction of 4-hydroxy-3-methoxyphenylacetone (1) and N-benzylmaleimide (2).
Figure 1
Figure 1
The organ weight and body weight in response to the treatment of the synthesized compound in diabetic mice. The results are presented as mean ± SE (n = 3), ** p < 0.01; * p < 0.05; vs. control group, # p < 0.05; ## p < 0.01 vs. STZ group. Metformin (MET) and streptozotocin (STZ). Tg-1 (control), Tg-2 (STZ), Tg-3 (compound 3), Tg-4 (STZ + metformin), and Tg-5 (STZ + compound 3).
Figure 2
Figure 2
Effect of compound 3 treatments on plasma insulin and serum lipid profile of diabetic mice. The results are presented as mean ± SEM (n = 3), ** p < 0.01, and * p < 0.05; vs. control group, # p < 0.05; ## p < 0.01 vs. STZ group. Metformin (MET) and streptozotocin (STZ). Low-density lipoprotein (LDL), and high-density lipoprotein (HDL). Control (Tg-1), STZ (Tg-2), compound 3 (Tg-3), STZ + metformin (Tg-4), and STZ + compound 3 (Tg-5).
Figure 3
Figure 3
Effect of compound 3 on serum markers ALT, AST, ALP, BUN, and creatinine level in diabetic mice. The results are presented as mean ± SEM (n = 3), ** p < 0.01, and * p < 0.05; vs. control group, # p < 0.05; ## p < 0.01 vs. STZ group. Aspartate transaminase (AST), alanine transaminase (ALT), blood urea nitrogen (BUN), and alkaline phosphatase (ALP). Tg-1 (control), Tg-2 (STZ), Tg-3 (compound 3), Tg-4 (STZ + metformin), and Tg-5 (STZ + compound 3).
Figure 4
Figure 4
Effect of the tested synthesized compound treatments on histology of the liver (A), kidneys (B), and pancreas (C) of diabetic mice.
See this image and copyright information in PMC

References

    1. Elsayed M.S., El Badawy A., Omar R., Mohamed A. Serum cystatin C as an indicator for early detection of diabetic nephropathy in type 2 diabetes mellitus. Diabetes Metab. Syndr. Clin. Res. Rev. 2019;13:374–381. doi: 10.1016/j.dsx.2018.08.017. - DOI - PubMed
    1. Lawal M., Verma A.K., Umar I.A., Gadanya A.M., Umar B., Yahaya N., Auwal B. Analysis of New Potent Anti-Diabetic Molecules from Phytochemicals of PistiaStrateotes with Sglt1 and G6pc Proteins of Homo Sapiens for Treatment of Diabetes Mellitus. An In SilicoApproach. Silico Approach IOSR JPBS. 2020;15:59–73.
    1. Mirzaei F., Khodadadi I., Vafaei S.A., Abbasi-Oshaghi E., Tayebinia H., Farahani F. Importance of hyperglycemia in COVID-19 intensive-care patients: Mechanism and treatment strategy. Prim. Care Diabetes. 2021;15:409–416. doi: 10.1016/j.pcd.2021.01.002. - DOI - PMC - PubMed
    1. Zhang S., Guo F., Yu M., Yang X., Yao Z., Li Q., Wei Z., Feng K., Zeng P., Zhao D. Reduced Nogo expression inhibits diet-induced metabolic disorders by regulating ChREBP and insulin activity. J. Hepatol. 2020;73:1482–1495. doi: 10.1016/j.jhep.2020.07.034. - DOI - PubMed
    1. Zheng W., Chen L., Chen J.-H., Lin X., Tang Y., Lin X.-J., Wu J., Lin Z.-M., Lin J.-Y. Hemichorea associated with non-ketotic hyperglycemia: A case report and literature review. Front. Neurol. 2020;11:96. doi: 10.3389/fneur.2020.00096. - DOI - PMC - PubMed

LinkOut - more resources